Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
1.570
+0.030 (1.95%)
Aug 14, 2025, 2:12 PM - Market open

Senti Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
41162962291-
Upgrade
Market Cap Growth
335.63%-45.22%-52.46%-78.72%--
Upgrade
Enterprise Value
504027-21274-
Upgrade
Last Close Price
1.543.516.6014.1098.60-
Upgrade
PS Ratio
--11.4814.43105.23-
Upgrade
PB Ratio
1.630.320.440.494.81-
Upgrade
P/TBV Ratio
1.630.630.440.49--
Upgrade
EV/Sales Ratio
--10.40-99.22-
Upgrade
Debt / Equity Ratio
1.270.660.560.290.380.45
Upgrade
Asset Turnover
--0.020.030.040.01
Upgrade
Quick Ratio
2.543.844.245.563.976.35
Upgrade
Current Ratio
3.264.495.625.684.146.52
Upgrade
Return on Equity (ROE)
-169.54%-89.73%-85.91%-52.94%-121.15%-81.21%
Upgrade
Return on Assets (ROA)
-45.98%-31.22%-26.83%-27.97%-34.86%-36.66%
Upgrade
Return on Capital (ROIC)
-52.61%-35.90%-29.95%-31.36%-39.47%-39.69%
Upgrade
Earnings Yield
-151.02%-327.76%-241.69%-94.13%-19.04%-
Upgrade
FCF Yield
-120.88%-257.19%-219.16%-123.34%-13.83%-
Upgrade
Buyback Yield / Dilution
-151.57%-3.58%-69.93%-796.58%78.99%-2.03%
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q